109 related articles for article (PubMed ID: 19782398)
1. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.
Kim M; Oh B; Kim SY; Park HK; Hwang SM; Kim TY; She CJ; Yang I; Yoon SS; Yoon JH; Lee DS
Leuk Res; 2010 Jun; 34(6):718-22. PubMed ID: 19782398
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia.
Wang H; Wang XQ; Xu XP; Lin GW
Eur J Haematol; 2009 Dec; 83(6):550-8. PubMed ID: 19737310
[TBL] [Abstract][Full Text] [Related]
5. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
[TBL] [Abstract][Full Text] [Related]
6. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
10. Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes.
Kim M; Chung S; See CJ; Yoon SS; Kim BK; Kim HK; Lee DS
Leuk Res; 2012 Feb; 36(2):163-8. PubMed ID: 21920602
[TBL] [Abstract][Full Text] [Related]
11. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
12. Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome.
Wang H; Zhang TT; Jin S; Liu H; Zhang X; Ruan CG; Wu DP; Han Y; Wang XQ
Clin Epigenetics; 2017; 9():91. PubMed ID: 28861128
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias.
Yalcin A; Serin MS; Emekdas G; Tiftik N; Aslan G; Eskandari G; Tezcan S
Int J Lab Hematol; 2009 Aug; 31(4):407-19. PubMed ID: 18384396
[TBL] [Abstract][Full Text] [Related]
14. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr WR; Welterman A; Schwarzinger I; Frommlet F; Haas OA; Valent P; Lechner K; Geissler K; Ohler L
Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
[No Abstract] [Full Text] [Related]
16. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
17. High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.
Calvo X; Nomdedeu M; Navarro A; Tejero R; Costa D; Muñoz C; Pereira A; Peña O; Risueño RM; Monzó M; Esteve J; Nomdedeu B
Leuk Res; 2014 Aug; 38(8):874-81. PubMed ID: 24880536
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome.
Gonzalez-Porras JR; Cordoba I; Such E; Nomdedeu B; Vallespi T; Carbonell F; Luño E; Ardanaz M; Ramos F; Pedro C; Gomez V; de Paz R; Sanchez-Barba M; Sanz GF; Del Cañizo AC;
Cancer; 2011 Dec; 117(24):5529-37. PubMed ID: 21638279
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Cancer Genet Cytogenet; 2010 Jan; 196(2):159-66. PubMed ID: 20082852
[TBL] [Abstract][Full Text] [Related]
20. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]